MAPT and Alzheimer disease: Ebselen decreased the expression of amyloid precursor protein and β-secretase, reduced the levels of Aβ in AD neurons, especially the most toxic oligomeric form, and decreased phosphorylation of tau protein while increasing glutathione peroxidase and superoxide dismutase activities (Xie et al., 2017).